Robert J. Deluccia
Director · Acurx Pharmaceuticals, Inc.
Individual
- 2026
- Apr 22, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Robert J. Deluccia's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert J. Deluccia?
Robert J. Deluccia is a corporate insider, tracked as Director of Acurx Pharmaceuticals, Inc. (ACXP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Robert J. Deluccia last file a Form 4?
The only primary Form 4 on record is dated 22 April 2026.